卡瑞利珠单抗联合阿帕替尼用于可切除肝细胞癌围手术期治疗的初步有效性与安全性

评价者：金浩生^a, 陈志鸿^a, 石宁^a, 文献合成者：吕玲^b

Preliminary Efficacy and Safety of Perioperative Treatment of Camrelizumab Combined With Apatinib in Resectable Hepatocellular Carcinoma

Reviewers: JIN Hao-sheng^a, CHEN Zhi-hong^a, SHI Ning^a, Literature Co-worker: LV Ling^b